GL
IMVT icon

Governors Lane’s Immunovant IMVT Stock Holding History

Governors Lane’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-828,004
Closed -$8.21M – 54
2019
Q3 		$8.21M Buy
+828,004
New +$8.17M 1.09% 33

Other funds holding IMVT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Governors Lane's IMVT Position: Q4 2019 in Review

Governors Lane sold out of Immunovant (IMVT) in Q4 2019, closing a stake of 828,004 shares — an estimated $8.21M sold.

Governors Lane first reported a position in IMVT in Q3 2019 and held it in 1 quarter. The position peaked at $8.21M in Q3 2019. 24 funds tracked by Wall St. Rank hold IMVT as of Q4 2019.

  • Governors Lane reported no remaining Immunovant position as of Q4 2019 after selling out during the quarter.
  • Governors Lane sold 828,004 Immunovant shares in Q4 2019, an estimated $8.21M.
  • Governors Lane first reported a position in Immunovant in Q3 2019 and held it in 1 quarter.
  • Governors Lane's Immunovant position peaked at $8.21M in Q3 2019.
  • 24 funds tracked by Wall St. Rank held Immunovant as of Q4 2019.

Based on Governors Lane's 13F filing for Q4 2019, filed 14 Feb 2020.